在帕金森病患者中皮质层深度变化 患有勒沃多巴诱导的运动障碍症的患者
Qianqian Si1, Caiting Gan1, Jiaxin Shi1
1Department of Neurology, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, Jiangsu, China.
Journal of integrative neuroscience
|December 6, 2025
概括
患有勒沃多巴诱导的运动障碍的帕金森病患者在特定的大脑区域的皮质深度减少. 这些结构变化,特别是在皮层,与运动障碍的严重程度有关,可以帮助区分PD亚型.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 放射学 放射学是一门学科.
背景情况:
- 帕金森病 (PD) 通常涉及运动并发症,如长期治疗的Levodopa诱导的运动障碍症 (LID).
- 在LID背后的精确神经机制仍然不清楚.
- 了解这些机制对于管理PD进展至关重要.
研究的目的:
- 为了研究皮质和皮质下皮质结构差异在PD患者和没有LID.
- 为了将结构性大脑变化与LID严重程度相关联.
- 评估这些结构标记物的诊断潜力.
主要方法:
- 结构性脑成像 (T1加权) 和来自62名PD患者 (30名有LID,32名没有) 和30名健康对照 (HC) 的临床数据.
- 量化区域深 (SD) 和地皮下体积.
- 包括邦费罗尼校正和接收器运行特征 (ROC) 曲线分析在内的统计分析.
主要成果:
- 与没有LID和HC的PD患者相比,患有LID的PD患者在右下巴底和胰皮层中表现出减少的区域SD.
- 在两种PD亚型和HC中,右门体积都减少了.
- 右下垂体SD与LID严重程度负相关 (r = -0.494,p = 0.017).右下垂体SD与LID严重程度负相关 (r = -0.494,p = 0.017).
- 结合皮质SD值,实现了在区分PD-LID和PD-NLID (AUC=0.913) 中的高诊断准确度.
结论:
- 在LID的结构性变化涉及皮质的变化,从前部延伸到顶部和岛屿区域.
- 这些区域的皮层SD降低可能是LID的关键神经因素.
- 这些发现提高了对帕金森病中LID神经基础的理解.
相关概念视频
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K


